Kala Pharmaceuticals (KALA:NAS) Fundamental Valuation Report
Fundamental Valuation Report Kala Pharmaceuticals(KALA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.45 (USD) 05/04/2021 Weighted Valuation$6.67 (USD) Overall RatingFairly valued to slightly Undervalued by 3.4% Valuation Models Adjusted …
Kala Pharmaceuticals (KALA:NAS) Fundamental Valuation Report Read more »
Read More